Spectral bio-imaging diagnostics systems. Electro-optical
equipment.
Employees: 25
Overview
APPLIED SPECTRAL IMAGING Ltd. (ASI) is a leading provider of
Available R&D facilities Click here to request more information, about this company (FOR COLLABORATION IN R&D. ONLY!)
Note - you have to be registered in this server to
request information. If you haven't done so
yet, please register in this server
Your requests will be forwarded to the developer, who
will contact you directly
You can also see the list of
documents you already requested more information about
cytogenetics systems to prestigious clinical and research labs
all over the world. Its CytoLabView suite offers a complete
solution for all imaging needs in the lab and includes
applications for karyotyping, FISH, CGH, multi-color karyotyping
and general spectral imaging.
The Company will continue to develop products to expand its
competitive offerings in the market to include its new automatic
scanning platform, ScanView. ScanView is created on an open and
modular platform on which common hardware allows the use of
different software modules for a variety of applications in
genetics, hematology, pathology and much more.
Applied Spectral Imaging LTD (ASI) has developed a light related
platform imaging technology called SpectraCube. Patented
worldwide, SpectraCube can distinguish between materials that
appear identical and provides qualitative and quantitative
analysis of light in the visible and NIR spectrum. In 1997, ASI
was awarded the European Information Technology Grand Prize for
successful commercialization of SpectraCube -an achievement which
revolutionized the entire fields of clinical and research
cytogenetics.
Applied Spectral Imaging, Ltd. founded in 1993, develops and
markets state-of-the-art imaging systems for the life sciences
and health care markets. The company commercialized its patented
technology for both the qualitative and quantitative analysis of
light in the visible spectrum. ASI's patented technology can
separate overlapping waveforms and light and display them in a
two-dimensional image.
ASI Ltd. is responsible for the research, development and
manufacturing of ASI's products and is compliant with
internationally recognized quality standards (FDA, CE, ISO
9000-3).
ASI offers a complete line of cytogenetics imaging products
called CytoLabView: which includes its FDA approved BandView
EXPO, automated karyotyping systems; FISHView EXPO, FISH imaging
systems; SKYView EXPO, spectral karyotyping; its newly released
CGHView EXPO, High-Resolution Comparative Genomic Hybridization;
Multi-Species, Multi-Species automated karytoyping.
ASI's patented technology uses interferometry and/or filters to
acquire an image in which every pixel of that image contains
information on the intensity of each wavelength of light over the
visible spectrum. These images can be of either microscopic
structures (e.g. cell organelles) or macroscopic subjects (an
entire array). ASI's SpectraCube technology is based on spectral
imaging, which combines two existing technologies, CCD-imaging
and spectrometry. CCD imaging produces a finely detailed
monochrome image of an object. Spectrometry, on the other hand,
measures the spectrum of selected areas on the object and then
displays each spectrum as a separate graph. The SpectraCube
system is made up of an interferometer, a CCD-camera, a computer,
and spectral image analysis software. The spectral imaging system
has two viewing modes: Interferometer mode and Direct View mode.
R&D employees: 13
